JPM26:中外制药借力美国生物制药行业,追求新科学与品牌知名度
JPM26: Chugai chases new science and name recognition from US biopharma industry
生物技术与制药领域的最新动态
JPM26: Chugai chases new science and name recognition from US biopharma industry
Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai
On biotech’s biggest stage, renewed excitement gets a stress test
Waters Corporation $WAT Shares Sold by SG Americas Securities LLC - MarketBeat
A Weaverville facility produces 'humanity saving' equipment. Why is it closing? - The Asheville Citizen Times
Anthropic, Roche & NVIDIA: This Week's Top Stories - Healthcare Digital
Glial betaPix is essential for blood vessel development in the zebrafish brain
Stratification of viral shedding patterns in saliva of COVID-19 patients
Targeted computational design of an interleukin-7 superkine with enhanced folding efficiency and immunotherapeutic efficacy
Biologically informed cortical models predict optogenetic perturbations
Genetic Disease Research Solutions - Illumina
Nvidia Expands AI Healthcare Push With Lilly, Thermo Fisher - TechRepublic
New York sues ex-Emergent CEO over insider trading during vaccine manufacturing struggle
Trump unveils healthcare affordability plan
JPM26: Astellas CEO resists 'rescue BD' as $6B Xtandi patent cliff nears
Trump asks Congress to codify ‘most favored nation’ deals
The newest women’s health unicorn
Scientists turn cells’ most mysterious structures into spies on genetic activity
In fish, low doses of common pesticide speed aging and death
On a Galápagos island, a ‘restoration project on steroids’